Paul M. Tulkens
Paul M. Tulkens
Professor Emeritus / Professor invited
Verified email at - Homepage
Cited by
Cited by
Lysosomotropic agents
C De Duve, T De Barsy, B Poole, P Tulkens
Biochemical pharmacology 23 (18), 2495-2531, 1974
Aminoglycosides: activity and resistance
MP Mingeot-Leclercq, Y Glupczynski, PM Tulkens
Antimicrobial agents and chemotherapy 43 (4), 727-737, 1999
Tackling antibiotic resistance
K Bush, P Courvalin, G Dantas, J Davies, B Eisenstein, P Huovinen, ...
Nature Reviews Microbiology 9 (12), 894-896, 2011
Aminoglycosides: nephrotoxicity
MP Mingeot-Leclercq, PM Tulkens
Antimicrobial agents and chemotherapy 43 (5), 1003-1012, 1999
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
N Mesaros, P Nordmann, P PlÚsiat, M Roussel-Delvallez, J Van Eldere, ...
Clinical microbiology and infection 13 (6), 560-578, 2007
Antibiotic efflux pumps
F Van Bambeke, E Balzi, PM Tulkens
Biochemical pharmacology 60 (4), 457-470, 2000
Quinolones in 2005: an update
F Van Bambeke, JM Michot, J Van Eldere, PM Tulkens
Clinical Microbiology and infection 11 (4), 256-280, 2005
Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial
A Spinewine, C Swine, S Dhillon, P Lambert, JB Nachega, L Wilmotte, ...
Journal of the American Geriatrics Society 55 (5), 658-665, 2007
Tissue concentrations: do we ever learn?
JW Mouton, U Theuretzbacher, WA Craig, PM Tulkens, H Derendorf, ...
Journal of Antimicrobial Chemotherapy 61 (2), 235-237, 2008
Intracellular distribution and activity of antibiotics
PM Tulkens
European journal of clinical microbiology and infectious diseases 10, 100-106, 1991
Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages
M Barcia-Macay, C Seral, MP Mingeot-Leclercq, PM Tulkens, ...
Antimicrobial agents and chemotherapy 50 (3), 841-851, 2006
Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
G Laurent, MB Carlier, B Rollman, F Van Hoof, P Tulkens
Biochemical pharmacology 31 (23), 3861-3870, 1982
Glycopeptide antibiotics: from conventional molecules to new derivatives
F Van Bambeke, Y Van Laethem, P Courvalin, PM Tulkens
Drugs 64, 913-936, 2004
Hepatic safety of antibiotics used in primary care
RJ Andrade, PM Tulkens
Journal of Antimicrobial Chemotherapy 66 (7), 1431-1446, 2011
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy
F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens
Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003
Early effects of gentamicin, tobramycin, and amikacin on the human kidney
ME De Broe, GJ Paulus, GA Verpooten, F Roels, N Buyssens, R Wedeen, ...
Kidney international 25 (4), 643-652, 1984
Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
H Servais, A Ortiz, O Devuyst, S Denamur, PM Tulkens, ...
Apoptosis 13, 11-32, 2008
Intracellular pharmacodynamics of antibiotics
S Carryn, H Chanteux, C Seral, MP Mingeot-Leclercq, F Van Bambeke, ...
Infectious Disease Clinics 17 (3), 615-634, 2003
Aminoglycoside-induced renal phospholipidosis and nephrotoxicity
G Laurent, BK Kishore, PM Tulkens
Biochemical pharmacology 40 (11), 2383-2392, 1990
Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motorá…
E Viaene, H Chanteux, H Servais, MP Mingeot-Leclercq, PM Tulkens
Antimicrobial agents and chemotherapy 46 (8), 2327-2332, 2002
The system can't perform the operation now. Try again later.
Articles 1–20